長城證券(002939.SZ):近日公司成功上線大模型DeepSeek-R1私有化版本、公有雲版本與阿里Qwen2.5私有化版本
格隆匯2月21日丨長城證券(002939.SZ)於近期投資者關係活動表示,2024年,公司智源AI中心項目上線OCR、活體識別、自然語言處理、檢索增強生成等多項AI技術,並建設完成了智能資訊問答、智能研報摘要、智能財富問答、報賬一問通等應用場景。近日,公司成功上線大模型DeepSeek-R1私有化版本、公有雲版本與阿里Qwen2.5私有化版本,並於近期就AI應用場景召開了業務研討會,後續將根據使用情況持續加大對AI技術、大數據分析、雲計算等領域的資源投入。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.